Suchergebnisse - "Bassi, Abhinav"

PubPharm (36)

1

Are Observational Reports on the Association of Dialysate Sodium with Mortality Enough to Change Practice? Perspective from the RESOLVE Study Team

enthalten in: Journal of the American Society of Nephrology : JASN | 2024

von Smyth, B. | Krishnasamy, R. | Jardine, M. | +20

2

Heterogeneity of treatment effect of higher dose dexamethasone by geographic region (Europe vs. India) in patients with COVID-19 and severe hypoxemia - a post hoc evaluation of the COVID STEROID 2 trial

enthalten in: The Lancet regional health. Southeast Asia | 2024

von Tirupakuzhi Vijayaraghavan, B. | Granholm, A. | Myatra, S. | +89

3

Angiotensin receptor blockers for the treatment of covid-19 : pragmatic, adaptive, multicentre, phase 3, randomised controlled trial

enthalten in: BMJ (Clinical research ed.) | 2022

von Jardine, M. | Kotwal, S. | Bassi, A. | +34

4

Innovative mobile-health led participatory approach to comprehensive screening and treatment of diabetes (IMPACT diabetes): rationale, design, and baseline characteristics

enthalten in: International journal of diabetes in developing countries | 2022

von Bassi, A. | Arfin, S. | John, O. | +5

5

Hydroxychloroquine plus personal protective equipment versus personal protective equipment alone for the prevention of laboratory-confirmed COVID-19 infections among healthcare workers : a multicentre, parallel-group randomised controlled trial from India

enthalten in: BMJ open | 2022

von Tirupakuzhi Vijayaraghavan, B. | Jha, V. | Rajbhandari, D. | +86

6

Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia

enthalten in: Intensive care medicine | 2022

von Granholm, A. | Kjær, M. | Munch, M. | +46

7

Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia

enthalten in: Intensive care medicine | 2022

von Granholm, A. | Kjær, M. | Munch, M. | +46

8

Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia

enthalten in: Intensive care medicine | 2022

von Granholm, A. | Kjær, M. | Munch, M. | +46

9

Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia

enthalten in: Intensive care medicine | 2022

von Granholm, A. | Kjær, M. | Munch, M. | +46

10

Challenges in operationalising clinical trials in India during the COVID-19 pandemic

enthalten in: The Lancet. Global health | 2022

von Bassi, A. | Arfin, S. | Joshi, R. | +6

CommentIn: Lancet Glob Health. 2022 Jul;10(7):e953. - PMID 35714642